Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCt Global Grwth Regulatory News (CMPG)

Share Price Information for Ct Global Grwth (CMPG)

Share Price is delayed by 15 minutes
Get Live Data
324.00    -2.00 (-0.61%)
Bid:
320.00
Ask:
328.00
Spread: 8.00 (2.50%)
Market Cap: £307.84m
CMPG Live PriceLast checked at - London Stock Exchange

Intraday Ct Global Grwth Share Chart

Directorate change

19 Feb 2026 11:08

RNS Number : 7012T
CT Global Managed Portfolio Trust
19 February 2026
 

To: RNS

From: CT Global Managed Portfolio Trust PLC

Date: 19 February 2026

LEI: 213800ZA6TW45NM9YY31

 

 

CT Global Managed Portfolio Trust PLC ('the Company')

 

Directorate Change

 

Appointment of Non-Executive Director and Chair of the Marketing Committee

Information disclosed in accordance with paragraph 6.4.6R of the Financial Conduct Authority's UK Listing Rules.

 

Following a formal recruitment process and a search conducted by an independent agency, the Board of the Company is pleased to announce the appointment of Roland Spencer as a non-executive director of the Company with effect from 19 February 2026. From this date, Roland will also chair the Marketing Committee, in place of David Warnock.

 

Roland has twenty-five years' experience in the financial sector, including eighteen years in the UK direct‑to‑consumer investments and platform market. His most recent role was Head of New Business at AJ Bell where he previously held a number of senior positions covering AJ Bell Media, corporate development, marketing and product proposition between 2012 to 2025. A recognised industry expert, Roland is a regular speaker at events on retail investor engagement.

 

Roland Spencer, and his Persons Closely Associated to him, do not own any Income shares or Growth shares in the Company and his election will be proposed to shareholders for approval at the Annual General Meeting of the Company currently scheduled to be held in September 2026.

 

There is no other information required to be disclosed pursuant to paragraph 6.4.8R of the Financial Conduct Authority's UK Listing Rules in relation to this appointment.

 

David Warnock, Chairman commented:

 

'We are delighted to welcome Roland as a non-executive director of the Company and believe that his experience of marketing, the direct-to-consumer market and retail investor engagement will add considerable value to the Board.'

 

 

For further information contact:

 

Ian Ridge

Columbia Threadneedle Investment Business Limited

Company Secretary

 

Tel: 0131 573 8300

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPURUPUPQGGB
Date   Source Headline
29th Apr 20264:22 pmRNSIssue of Equity
29th Apr 202612:50 pmRNSNet Asset Value(s)
28th Apr 202612:49 pmRNSNet Asset Value(s)
27th Apr 202612:45 pmRNSNet Asset Value(s)
24th Apr 202612:51 pmRNSNet Asset Value(s)
23rd Apr 20264:43 pmRNSIssue of Equity
23rd Apr 20262:16 pmRNSPortfolio Update
23rd Apr 202612:36 pmRNSNet Asset Value(s)
22nd Apr 202612:50 pmRNSNet Asset Value(s)
21st Apr 202612:51 pmRNSNet Asset Value(s)
20th Apr 202612:31 pmRNSNet Asset Value(s)
17th Apr 20261:54 pmRNSNet Asset Value(s)
16th Apr 202612:48 pmRNSNet Asset Value(s)
15th Apr 202612:38 pmRNSNet Asset Value(s)
14th Apr 202612:25 pmRNSNet Asset Value(s)
13th Apr 202612:41 pmRNSNet Asset Value(s)
10th Apr 202612:38 pmRNSNet Asset Value(s)
9th Apr 202612:31 pmRNSNet Asset Value(s)
8th Apr 20264:51 pmRNSIssue of Equity
8th Apr 202612:54 pmRNSNet Asset Value(s)
7th Apr 202612:54 pmRNSNet Asset Value(s)
1st Apr 20264:41 pmRNSIssue of Equity
1st Apr 202612:57 pmRNSNet Asset Value(s)
31st Mar 202612:21 pmRNSNet Asset Value(s)
30th Mar 202612:34 pmRNSNet Asset Value(s)
27th Mar 202612:39 pmRNSNet Asset Value(s)
26th Mar 202612:41 pmRNSNet Asset Value(s)
25th Mar 202612:37 pmRNSNet Asset Value(s)
24th Mar 202612:41 pmRNSNet Asset Value(s)
23rd Mar 202612:37 pmRNSNet Asset Value(s)
20th Mar 202612:54 pmRNSNet Asset Value(s)
19th Mar 20261:40 pmRNSNet Asset Value(s)
18th Mar 202612:35 pmRNSNet Asset Value(s)
17th Mar 202612:39 pmRNSNet Asset Value(s)
16th Mar 202612:31 pmRNSNet Asset Value(s)
12th Mar 20265:21 pmRNSPortfolio Update
10th Mar 202612:58 pmRNSNet Asset Value(s)
9th Mar 202612:44 pmRNSNet Asset Value(s)
6th Mar 202612:42 pmRNSNet Asset Value(s)
6th Mar 202612:11 pmRNSPortfolio Update
6th Mar 202612:10 pmRNSPortfolio Update
5th Mar 20263:12 pmRNSDirector/PDMR Shareholding
5th Mar 20261:00 pmRNSNet Asset Value(s)
4th Mar 202612:27 pmRNSNet Asset Value(s)
3rd Mar 202612:43 pmRNSNet Asset Value(s)
2nd Mar 20262:16 pmRNSTotal Voting Rights
2nd Mar 202612:39 pmRNSNet Asset Value(s)
27th Feb 20261:23 pmRNSNet Asset Value(s)
26th Feb 202612:32 pmRNSNet Asset Value(s)
25th Feb 202612:50 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.